Imagine Eyes appoints Marine Durand as its product manager for retinal imaging devices
We warmly welcomes a new recruit, Marine Durand, who will strengthen our company’s marketing team as Product Manager, Retinal Imaging Devices. Read more
First installation of an adaptive optics retinal camera in Northern Ireland
Imagine Eyes’ team is proud to announce that Queen’s University Belfast, Northern Ireland, United Kingdom is now the owner of an rtx1-e Adaptive Optics Retinal Camera. The new imaging device has been installed at the university’s Northern Ireland Clinical Research Facility (NICRF), at the Belfast City Hospital.
Franck Martins appointed as Opto-mechanical Designer at Imagine Eyes
Appointed as an Opto-mechanical Designer at Imagine Eyes, Franck Martins will play a key role in designing and engineering the company’s innovative retinal imaging devices. Franck’s main focus is to combine new functionality with high reliability and great usability, driven by clinical customers’ needs. Read more
Nicolas Lefaudeux appointed as R&D project leader at Imagine Eyes
Imagine Eyes’ team warmly welcomes a new recruit, Nicolas Lefaudeux, who will lead R&D projects to further develop the company’s brand of innovative retinal imaging products. “I am thrilled to join Imagine Eyes and tackle the challenge of delivering advanced retinal imaging products that will strongly benefit visual health. I also see my new job as a superb opportunity to collaborate with leading scientific and medical experts in an international context”, says Nicolas. “I have absolutely no doubt that Nicolas’ talents and experience will be key advantages for bringing our ambitious R&D program to fruition”, adds Xavier Levecq, CTO at Imagine Eyes.
Lecture on rtx1 imaging in inherited retinal diseases
Clinical results obtained with the rtx1 Adaptive Optics Camera will be presented at the 2nd Conference of the Ophthalmology Journal « Update in Ophthalmology » on February 10th, 2018, in Lublin, Poland.
Publication assesses cone cell density in a large number of healthy retinas
Assessing cone cell density is of key importance for research in inherited retinal diseases that affect cone photoreceptor cells. A new milestone has been reached with an article recently published in the Plos One journal, which provides statistics of the spatial distribution of cone cells in a population of 109 healthy subjects. The measurements were based on images acquired using the rtx1 Adaptive Optics Retinal Camera.
Conférence et démonstration publiques: imagerie par optique adaptative des vaisseaux sanguins de la rétine
Des ophtalmologistes et des chercheurs du Centre National d’Ophtalmologie des Quinze-Vingts présentent des démonstrations ainsi qu’une conférence sur l’imagerie à ultra-haute résolution des vaisseaux sanguins de la rétine lors d’une Conférence Expérimentale de l’ESPCI, à Paris le 12 février 2018. Ces présentations sont ouvertes à tout public.
European consortium is awarded with € 5 million in funding to deliver breakthrough retinal imaging technology
Paris, France, 2018/01/26. A consortium of European industrial, scientific and medical partners has met for 2 days in Paris to kick off the MERLIN project, with the common ambition of developing breakthrough medical instrumentation for imaging the back of the eye. The medical applications of MERLIN encompass a wide range of pathologies that impact the eye’s retina, including age-related macular degeneration (AMD), as well as chronic vascular conditions, including diabetes. This project has received € 4.868M in funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 780989.
rtx1 clinical results in inherited diseases at JSCEV 2017
Several users of the rtx1 Adaptive Optics Retinal Camera present new clinical results at the 65th Meeting of the Japanese Society for Clinical Electrophysiology of Vision (JSCEV), in Osaka on November 17-18, 2017.
rtx1 users present clinical results at Euretina 2017
Several users of the rtx1 Adaptive Optics Retinal Camera will present new clinical results at the Euretina 2017 meeting, in Barcelona on Sept 7-10.